There is a great and ever increasing socioeconomic burden on Europe due to the prevalence of people with multiple chronic diseases. CLOSE (Automated glucose control at home for people with chronic disease) serves to innovate homecare for insulin treated patients with type 2 diabetes mellitus (T2DM) by offering an integrated product and service package (AP+). Blood glucose levels will be controlled by an artificial pancreas (AP) that will be installed at the patients' home, operated through trained caregivers, and remote controlled (telehealth).
Profil is very proud of being the organisation coordinationg CLOSE which is part of the EIT Health innovation project portfolio. For further information we invite you to read the recent interview of our Director of Science & Innovation, Prof. Dr. Freimut Schliess, about the implementation of the project and the collaborative approach behind.